Indication

Community-acquired Bacterial Pneumonia

1 clinical trial

2 products

Clinical trial

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline IV/PO to Moxifloxacin IV/PO for Treating Adult Subjects With Community-acquired Bacterial Pneumonia (CABP)

Status: Recruiting, Estimated PCD: 2025-01-01

Product

Product